Feng L, Chao J, Ye P, Luong Q, Sun GQ, Liu W, Cui Q, Flores S, Jackson N, Shayento ANazmul Hoq, et al. Developing Hypoimmunogenic Human iPSC-Derived Oligodendrocyte Progenitor Cells as an Off-The-Shelf Cell Therapy for Myelin Disorders. Adv Sci (Weinh). 2023:e2206910.